Metrics to compare | MOLB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMOLBPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | 16.7x | −0.4x | |
PEG Ratio | 0.00 | 0.07 | 0.00 | |
Price/Book | 0.0x | 1.8x | 2.6x | |
Price / LTM Sales | 0.0x | 2.0x | 3.1x | |
Upside (Analyst Target) | 0.0% | 47.1% | 48.3% | |
Fair Value Upside | Unlock | 5.7% | 6.2% | Unlock |
Molbio Diagnostics Limited, a point-of-care diagnostics company, provides healthcare technologies to diagnose infectious and non-communicable diseases. It manufactures and sells chip based diagnostic devices, chips and reagents, X-ray equipment's, and single/dual detectors. It also offers disposable POCT devices, which includes dengue, malaria, and COVID-19 tests; Tabletop analysers, a portable machine that are used to perform molecular or immunodiagnostic tests to detect infectious diseases, such as tuberculosis, human papillomavrus, STIs, and GI disorders. In addition, the company offers Truenat, a multi-disease real-time polymerase chain reaction platform that enables treatment decisions for various infectious and non-communicable diseases, such as tuberculosis, human immunodeficiency virus, malaria, viral hepatitis, COVID-19, dengue, chikungunya, influenza, H1N1, HPV/cervical cancer, cholera, leprosy, etc.; and Truenat assays. The company was incorporated in 2000 and is based in Verna, India.